Novartis | NVS - Trade Creditors

Stock Price
145.47
Daily Change
-2.06 -1.40%
Monthly
-3.46%
Yearly
29.62%
Q2 Forecast
142.62

Novartis reported $4.46B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bausch Health Companies USD 600M 16M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 715M 93M Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Glaxosmithkline GBP 20.72B 346.14M Dec/2025
J&J USD 10.46B 1.53B Mar/2026
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.46B 99M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Phibro Animal Health USD 133.3M 2.7M Dec/2025
Prestige Brands USD 42.95M 1.02M Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
Sanofi EUR 22.93B 2.89B Dec/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Zoetis USD 487M 77M Dec/2025